Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited inflammatory disorder, characterized by recurrent attacks of fever and serositis. Screening of mutations in the causing gene (MEFV) now allows accurate diagnosis of FMF among other inflammatory conditions. It is well documented that secreted levels of some pro-inflammatory cytokines are elevated in FMF. Here, we investigated cytokine expression at the transcriptional level, in patients that could be genetically ascertained. We have measured the transcript abundance of tumor necrosis factor α, interleukin-1β, interleukin-6 and interleukin-8, in circulating leukocytes and shown that these were more elevated in attack-free FMF patients than in controls (P = 0.01, P = 0.008, P = 0.02, P = 0.001 respectively). There was no significant difference according to MEFV genotype or colchicine treatment. Our results suggest that cytokine transcriptional pathways are misregulated in attack-free FMF patients, and further supports the hypothesis that these patients have subclinical inflammation between attacks.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Sohar E, Gafni J, Pras M, Heller H . Familial Mediterranean fever: a survey of 470 cases and review of the literature Am J Med 1967 43: 227–253

    Article  CAS  Google Scholar 

  2. Lachmann HJ, Booth DR, Booth SE et al. Serial monitoring of the acute phase response in healthy individuals with wild-type pyrin, heterozygous carriers of the FMF trait and patients with FMF Clin Exp Rheumatol 2000 18: 279 (Abstr. B4). Proceedings of the familial Mediterranean fever II international conference, 3–7 May 2000, Antalya, Turkey

    Google Scholar 

  3. Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN . Acute phase response and evolution of Familial Mediterranean fever (Letter) Lancet 1999 353: 1415

    Article  CAS  Google Scholar 

  4. The French FMF Consortium. A candidate gene for familial Mediterranean fever Nat Genet 1997 17: 25–31

  5. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever Cell 1997 90: 797–807

  6. Touitou I, Magne X, Molinari N et al. MEFV mutations in Behçet’s disease Hum Mutat 2000 16: 271–272

    Article  CAS  Google Scholar 

  7. Livneh A, Aksentijevich I, Langevitz P et al. A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet’s disease (FMF-BD) Eur J Hum Genet 2001 9: 191–196

    Article  CAS  Google Scholar 

  8. Hawkins PN, Gillmore JD, Booth SE et al. Pyrin E148Q is prevalent globally and may upregulate the inflammatory response non-specifically Clin Exp Rheumatol 2000 18: 276 (Abstr. A4). Proceedings of the familial Mediterranean fever II international conference, 3–7 May 2000, Antalya, Turkey

    Google Scholar 

  9. Cattan D, Notarnicola C, Molinari N, Touitou I . Inflammatory bowel disease in non-Ashkenazi Jews with Familial Mediterranean fever Lancet 2000 355: 378–379

    Article  CAS  Google Scholar 

  10. Fidder HH, Langevitz P, Pras M, Livneh A . Crohn’s disease in patients with familial Mediterranean fever Clin Exp Rheumatol 2000 18: 300 (Abstr. F7). Proceedings of the familial Mediterranean fever II international conference, 3–7 May 2000, Antalya, Turkey

    Google Scholar 

  11. Fresko I, Masatioglu S, Melitlioglu M et al. The frequency of familial Mediterranean fever (FMF) among patients with Behcet’s syndrome (BD) Clin Exp Rheumatol 2000 18: 301 (Abstr. F11). Proceedings of the familial Mediterranean fever II international conference, 3–7 May 2000, Antalya, Turkey

    Google Scholar 

  12. Centola M, Wood G, Frucht DM et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators Blood 2000 95: 3223–3231

    CAS  PubMed  Google Scholar 

  13. Tidow N, Chen X, Müller C et al. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin Blood 2000 95: 1451–1455

    CAS  PubMed  Google Scholar 

  14. Papin S, Duquesnoy P, Cazeneuve C et al. Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin to the nucleus Hum Mol Genet 2000 9: 3001–3009

    Article  CAS  Google Scholar 

  15. Gang N, Drenth J, Langevitz P et al. Activation of the cytokine network in familial Mediterranean fever J Rheumatol 1999 26: 890–897

    CAS  PubMed  Google Scholar 

  16. Mege JL, Dilsen N, Sanguedolce V et al. Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL)-6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects J Rheumatol 1993 20: 1544–1549

    CAS  PubMed  Google Scholar 

  17. Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H . Serum soluble intracellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever J Rheumatol 1999 26: 1983–1986

    CAS  PubMed  Google Scholar 

  18. Kiraz S, Ertenli I, Arici M et al. Effects of inflammatory cytokines and selectins in familial Mediterranean fever Clin Exp Rheumatol 1998 16: 721–724

    CAS  PubMed  Google Scholar 

  19. Bernot A, Da Silva C, Petit JL et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF) Hum Mol Genet 1998 7: 1317–1325

    Article  CAS  Google Scholar 

  20. Rey JM, Pujol P, Callier P et al. Semi-quantitative reverse transcription-polymerase chain reaction to evaluate the expression patterns of genes involved in the oestrogen pathway J Mol Endocrinol 2000 24: 433–440

    Article  CAS  Google Scholar 

  21. Dewalle M, Domingo C, Rozenbaum M et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF) Eur J Hum Genet 1998 6: 95–97

    Article  CAS  Google Scholar 

  22. Shohat M, Magal N, Shohat T et al. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis Eur J Hum Genet 1999 7: 287–292

    Article  CAS  Google Scholar 

  23. Shinar Y, Livneh A, Langevitz P et al. Genotype-Phenotype assessment of common genotypes among patients with Familial Mediterranean fever J Rheumatol 2000 27: 1703–1707

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Centre Hospitalier de Montpellier. We are indebted to the FMF patients for their devoted contribution to this study. We thank Dr Mege for helpful discussion.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I Touitou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Notarnicola, C., Didelot, M., Seguret, F. et al. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 3, 43–45 (2002). https://doi.org/10.1038/sj.gene.6363813

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6363813

Keywords

This article is cited by

Search

Quick links